ライフサイエンスコーパス: blindness

1 neration (nAMD) tracked by the Fight Retinal Blindness!

2 ment-naive eyes enrolled in the Fight Retina Blindness!

3 sis and hydrocele, and onchocerciasis (river blindness).

4 eatment options to prevent visual damage and blindness.

5 rs of life and is a major cause of childhood blindness.

6 nd neonatal herpes and is a leading cause of blindness.

7 macular degeneration (AMD), a major cause of blindness.

8 m leading to ophthalmic artery occlusion and blindness.

9 function in a vertebrate model of inherited blindness.

10 risk factor for glaucoma, a leading cause of blindness.

11 children in rural India born with treatable blindness.

12 strophy would otherwise progress to complete blindness.

13 1), leads to retinal diseases culminating in blindness.

14 e optic nerve lead to reduced vision or even blindness.

15 at causes irreversible visual impairment and blindness.

16 e perimetric range from normal to perimetric blindness.

17 highest prevalence of visual impairment and blindness.

18 as a mechanism of cross-modal plasticity in blindness.

19 ind the pathogenesis of the CORD6 congenital blindness.

20 re, delay, but cannot prevent, RGC death and blindness.

21 o correct trachomatous trichiasis to prevent blindness.

22 (RP) is a primary cause of inherited retinal blindness.

23 n, resulting in a novel mouse model of night blindness.

24 ses are among the leading causes of acquired blindness.

25 e screening rates, thus reducing unnecessary blindness.

26 cular trauma is critical in order to prevent blindness.

27 for studying cataract, the leading cause of blindness.

28 rget and distractor leading to inattentional blindness.

29 ansplantation is proposed as a treatment for blindness.

30 nd their vulnerability to disease leading to blindness.

31 ited retinal dystrophy that causes childhood blindness.

32 d potentially reverse MPS1-associated cornea blindness.

33 -restoring drugs in humans with degenerative blindness.

34 ation, uncontrolled angiogenesis can lead to blindness.

35 ornea clouding with about 50% progressing to blindness.

36 nd functionally leading to legal or complete blindness.

37 featuring photoreceptor death that leads to blindness.

38 onal, and global strategies to fight corneal blindness.

39 evelopment of long-term disabilities such as blindness.

40 at can cause cold sores, genital herpes, and blindness.

41 perimentally induced animal model of corneal blindness.

42 logy, vision research, and the prevention of blindness.

43 llowing smallpox vaccination and can lead to blindness.

44 nked to autosomal-recessive stationary night blindness.

45 erately decreased vision, although not legal blindness.

46 eye constitute a leading cause of worldwide blindness.

47 omising visual acuity and often resulting in blindness.

48 tecedent of the current picture of childhood blindness.

49 giogenesis in the retina is a major cause of blindness.

50 ely leads to permanent visual impairment and blindness.

51 , elevated IOP, optic nerve degeneration and blindness.

52 ll of excessive inflammation at the cornea - blindness.

53 generate after damage, eventually leading to blindness.

54 ed retinal dystrophy that leads to premature blindness.

55 early case identification and prevention of blindness.

56 Damaged or diseased HCEnCs may cause blindness.

57 al targets for treatment of a major cause of blindness.

58 d its potential for severe VA impairment and blindness.

59 pment of bioelectronic implants for treating blindness.

60 ns may lead to impaired vision and, finally, blindness.

61 accounts for approximately 10% of childhood blindness.

62 ctural complications, visual impairment, and blindness.

63 elvic inflammatory disease, infertility, and blindness.

64 m of Leber congenital amaurosis and leads to blindness.

65 erlay resulted in the greatest inattentional blindness (20% recognition of unexpected finding by all

66 le to approximately 2.01 million people with blindness, 6.95 million people with VI, and 16.4 million

67 al loss that began at 3 mo and progressed to blindness 8 mo after birth was reversed by intraocular i

68 on deficiency (CVD), commonly called 'colour blindness', affects around 8% of men and 0.4% of women.

69 l keratitis is an important cause of corneal blindness all over the world.

70 These results suggest carriers of the blindness allele may be widely distributed across contem

71 a high prevalence and is the second cause of blindness among adults after cataract.

72 r degeneration (AMD) is the leading cause of blindness among older adults in the developed world.

73 ion (AMD) is a leading cause of irreversible blindness among the elderly population globally.

74 with a low prevalence of cataract (<22% for blindness and 14.1-15.9% for vision impairment) and a hi

75 ction were 5.1%, 8.6%, 12% and 15.6% for new blindness and 29.6%, 41.0%, 48.7%, and 53.7% for new sig

76 ractive error combined contributed to 55% of blindness and 77% of vision impairment in adults aged 50

77 ematode Onchocerca volvulus that can lead to blindness and chronic disability.

78 The adverse impact of visual impairment and blindness and correlations with socioeconomic position a

79 Evidence from inattentional blindness and emotion-induced blindness suggests that ca

80 cular degeneration (AMD) is a major cause of blindness and is associated with complement dysregulatio

81 of benign cold sores, but it can also cause blindness and life-threatening encephalitis.

82 Parasitic diseases including river blindness and lymphatic filariasis affect hundreds of mi

83 to treat human parasitic diseases like river blindness and lymphatic filariasis.

84 among the most common causes of irreversible blindness and manifests with choroidal neovascularizatio

85 correction) continue to cause most cases of blindness and moderate or severe vision impairment in ad

86 n913Arg) in an individual with low blood pH, blindness and neurological signs that resemble transient

87 Glaucoma is a common cause of vision loss or blindness and reduction of intraocular pressure (IOP) ha

88 etween 5 and 10 years of age, beginning with blindness and seizures, followed by progressive cognitiv

89 icenter real-world study on the incidence of blindness and sight impairment based on VA data in patie

90 The cumulative incidence of new blindness and sight impairment in patients with treated

91 and its results show low incidences of both blindness and sight impairment, which both declined duri

92 curved image sensor array exhibits infrared blindness and successfully acquires pixelated optical si

93 British Council for Prevention of Blindness and the Wellcome Trust.

94 Glaucoma is a significant cause of global blindness and there are, as yet, no effective means of s

95 Global and regional prevalence estimates for blindness and vision impairment are important for the de

96 Blindness and vision impairment at all ages in 2015 due

97 e common among women than among men, whereas blindness and vision impairment due to glaucoma (0.71 [0

98 rld regions varied markedly in the causes of blindness and vision impairment in this age group, with

99 estimates, trends, and projections of global blindness and vision impairment.

100 nsistently been listed as the major cause of blindness and visual disability in many of the developin

101 en-angle glaucoma (POAG) is a major cause of blindness and visual disability.

102 ) in adults examined in the Nigeria National Blindness and Visual Impairment Survey.

103 uction in the age-standardised prevalence of blindness and visual impairment, yet the growth and agei

104 for postoperative outcomes and the impact on blindness and visual impairment.

105 mage the structures of the eye with possible blindness and visual impairments.

106 nts to plaintiffs, and cases involving legal blindness and/or endophthalmitis were more likely to be

107 nted with photopsias, 56% (14/25) with night blindness, and 56% (14/25) with loss of peripheral visio

108 of the participants had visual impairment or blindness, and an additional 25678 (22.9%) had reduced v

109 Cerebral palsy, blindness, and deafness assessed by a pediatrician; cogn

110 n of Onchocerca volvulus, the agent of river blindness, and further population restructuring is expec

111 ive diseases are major causes of untreatable blindness, and novel approaches to treatment are being s

112 entosa, loss of cone photoreceptors leads to blindness, and preservation of cone function is a major

113 branches, resulting in aortic arch syndrome, blindness, and stroke.

114 Human retinal degeneration can cause blindness, and the lack of relevant model systems has ma

115 e highest projected per capita prevalence of blindness are Mississippi (0.83% in 2015 to 1.25% in 205

116 s by which human NCKX1 mutations cause night blindness are not understood.

117 The general effects of change blindness are usually thought to stabilize scene percept

118 y and cardiac surgery and leading to partial blindness as to the longer-term consequences of our inte

119 of age-related macular degeneration (>14% of blindness) as causes in the high-income subregions.

120 se characterized by abnormally acidic blood, blindness, as well as below average height and weight.

121 ns in this gene lead to cortical atrophy and blindness, as well as sleep abnormalities.

122 shed and various phenomena of 'inattentional blindness' associated with elimination of visual cortex

123 , a devastating genetic disorder that causes blindness, balance disorders and profound deafness, and

124 The overall age-adjusted prevalence of blindness (BCVA of </=20/200 in the better-seeing eye) w

125 rity (ROP) is the leading cause of childhood blindness, but current anti-VEGF therapy is concerned wi

126 Diabetic retinopathy is a leading cause of blindness, but its detrimental effects are preventable w

127 nical trials for patients with hemophilia or blindness, but pre-existing neutralizing antibodies (Nab

128 cular degeneration (AMD) is a major cause of blindness, but presents differently in Europeans and Asi

129 f visual impairment/severe visual impairment/blindness by 1.75 times (95% CI, 1.03-2.98) during this

130 n and progressive loss of vision, leading to blindness by the second decade of life.

131 Colour blindness can significantly impact quality of life for h

132 nopathy (PDR) are one of the major causes of blindness caused by neo-vascular changes in the retina.

133 antation is a potential future treatment for blindness caused by retinal degeneration.

134 Vision impairments and blindness caused by retinitis pigmentosa result from sev

135 tinitis pigmentosa (RP), a type of inherited blindness caused by the dysfunction and death of photore

136 dicine and Therapeutics, Research to Prevent Blindness, Center for Advanced Retinal and Ocular Therap

137 for such outcomes as cardiovascular disease, blindness, chronic kidney disease, and limb amputation.

138 urements from near normal to near perimetric blindness compared with linear and exponential functions

139 Visual impairment (VI) and blindness continue to be major public health problems wo

140 Congenital stationary night blindness (CSNB) is a heterogeneous group of non-progres

141 rom experiencing unnecessary vision loss and blindness, decrease associated costs to the US economy f

142 Outcomes and Measures: Visual impairment and blindness (defined according to the World Health Organiz

143 e most common cause of X-linked RP, a severe blindness disorder.

144 lable to restore vision for individuals with blindness due to corneal endothelial dysfunction.

145 Retinitis pigmentosa results in blindness due to degeneration of photoreceptors, but spa

146 cluding microcephaly, cortical thinning, and blindness during early development.

147 ere retinal degenerative disease that causes blindness during infancy.

148 (ROP) causes 100,000 new cases of childhood blindness each year.

149 y (DR) which is one of the leading causes of blindness, especially in developing countries.

150 s and persistent severe low visual acuity or blindness for 5 patients.

151 generation (AMD) is the most common cause of blindness for individuals age 50 and above in the develo

152 oroidal neovascularization, a major cause of blindness for patients with age-related macular degenera

153 Age-specific prevalence and causes of VI and blindness for presenting and BCVA.

154 , degenerative retinal disease that leads to blindness for which no therapy is available.

155 ited retinal degeneration (RD) that leads to blindness for which no treatment is available.

156 etinal dystrophies are an important cause of blindness, for which currently there are no effective tr

157 ary data for causes of vision impairment and blindness form an important basis of recommendations in

158 serve vision, he founded Research to Prevent Blindness, founded the Jules Stein Eye Institute at the

159 data for the causes of vision impairment and blindness from 1980 to 2014.

160 in blindness with only (28 %) affirming that blindness from glaucoma is irreversible.

161 d in current retinal prostheses for treating blindness from photoreceptor degenerative diseases.

162 Early detection can reduce irreversible blindness from retinal diseases.

163 h glaucoma is the lead cause of irreversible blindness globally, the condition shows no signs or symp

164 is one of the leading causes of preventable blindness globally.

165 , diabetes, chronic respiratory disease, and blindness health programmes; provision of enhanced labor

166 s population with consequences such as night blindness, higher child mortality, anemia, poor pregnanc

167 e can lead to permanent visual impairment or blindness if medical attention is delayed.

168 ted in 22.3%, low vision in 29.7%, and legal blindness in 48.0%.

169 ptor degeneration is a cause of irreversible blindness in a number of retinal diseases such as retini

170 iabetic retinopathy is an important cause of blindness in adults, and is characterized by progressive

171 design of interventions to prevent glaucoma blindness in Africa.

172 loss are irreversible, and lead to bilateral blindness in approximately 14% of all diagnosed patients

173 Cataract is a common cause of avoidable blindness in children globally.

174 genital glaucoma (PCG) is a leading cause of blindness in children worldwide and is caused by develop

175 ic retinopathy is a frequent cause of VI and blindness in Chinese Americans that has not been commonl

176 Cataract, one of the most frequent causes of blindness in developed countries, is strongly associated

177 lar degeneration (AMD) is a leading cause of blindness in developed countries.

178 , it is also the leading cause of infectious blindness in developed countries.

179 it is also the leading source of infectious blindness in developed countries.

180 Cataract is the leading cause of blindness in developing countries and identification of

181 Corneal ulcer, a major cause of monocular blindness in developing countries has consistently been

182 n cell death, is the primary risk factor for blindness in glaucoma patients.

183 and by hemorrhagic fever, encephalitis, and blindness in humans.

184 ants and hemorrhagic fever, encephalitis, or blindness in humans.

185 is one of the leading causes of preventable blindness in low and middle income countries.

186 Cataract still remains the leading cause of blindness in middle-income and low-income countries.

187 oncern, has recently been affected by lethal blindness in nestlings.

188 role in preventing glaucoma vision loss and blindness in people of African descent living in resourc

189 prematurity (ROP), the most common cause of blindness in premature infants, has long been associated

190 lar neovascularization is a leading cause of blindness in proliferative retinopathy.

191 betic retinopathy (PDR) is a common cause of blindness in the developed world's working adult populat

192 betic retinopathy (DR), the leading cause of blindness in the developed world, remains controversial.

193 macular degeneration is the leading cause of blindness in the developed world.

194 r degeneration (AMD) is the leading cause of blindness in the developed world.

195 r degeneration (AMD) is the leading cause of blindness in the elderly, with limited therapeutic optio

196 lar degeneration, is the most common form of blindness in the elderly.

197 ing and the detection of avoidable causes of blindness in the most at-risk communities makes this an

198 primary visual cortex (V1) leads to clinical blindness in the opposite visual hemifield, yet nonconsc

199 iabetes, and is one of the leading causes of blindness in the UK working age population.

200 m 6 major population-based studies on VI and blindness in the United States.

201 plication of diabetes and a leading cause of blindness in the working-age population.

202 maculopathy is one of the leading causes of blindness in the world.

203 c neuropathy (DON) is the commonest cause of blindness in thyroid associated orbitopathy (TAO).

204 detection and treatment to prevent childhood blindness in world health organization programs.

205 coming the most common eye disorder to cause blindness in younger persons in many parts of the world.

206 Mutations in this gene cause childhood blindness, in which the a- and b-wave responses of elect

207 Severe pathologies from HSV include the blindness-inducing herpetic stromal keratitis, highly de

208 al Institutes of Health, Foundation Fighting Blindness, Institute for Translational Medicine and Ther

209 o visual impairment/severe visual impairment/blindness (International Statistical Classification of D

210 d characteristics of individuals with VI and blindness is especially important given the negative eff

211 ss that progresses from normal to perimetric blindness is important for treatment and prognostication

212 individuals with visual impairment (VI) and blindness is increasing in the United States and around

213 nal restoration of sight in certain forms of blindness is likely to occur in human patients in the ne

214 The prevalence of blindness is lower than that noted in other US or non-US

215 havior of glaucomatous VF loss to perimetric blindness is nonlinear and that its course of deteriorat

216 lved in rod phototransduction cascade; night blindness is the only symptom and eye examination is oth

217 man onchocerciasis - commonly known as river blindness - is one of the most devastating yet neglected

218 atment of glaucoma, a major leading cause of blindness, is challenging due to poor patient compliance

219 Diabetic retinopathy, a major cause of blindness, is characterized by a distinct phenotype.

220 annel result in a form of degenerative human blindness known as retinitis pigmentosa (RP).

221 racterized by severe childhood onset retinal blindness, Leber congenital amaurosis (LCA), and renal d

222 nt, 6/9.5 or better) to visual impairment or blindness (logMAR, 0.5 or worse; Snellen equivalent, 6/1

223 cation of diabetes and is a leading cause of blindness, mainly in adults of working age.

224 ) is the most common cause of inherited deaf-blindness, manifested as USH1, USH2 and USH3 clinical ty

225 Furthermore, in blindness, number-responsive visual cortices exhibited i

226 Blindness occurred at low frequency (affecting 1.6% of o

227 major global cause of visual impairment and blindness, often affecting marginalized populations.

228 graphs, maps, signals), the impact of colour blindness on everyday life is not generally considered a

229 is capable of large-scale reorganization in blindness or after massive injury.

230 ification System (GMFCS) level of 3 to 5, or blindness or hearing loss despite amplification.

231 % vs. 13%), visual disturbance (29% vs. 9%), blindness or low vision (5% vs. 0.5%), retinal detachmen

232 re associated with variable degrees of night blindness or photophobia, reduced visual acuity, high my

233 ldren, there remains no treatment to prevent blindness or restore vision in MPS1 children.

234 ary glaucoma or hypotony to be predictors of blindness or visual impairment during follow-up.

235 inopathy complications (vitreous hemorrhage, blindness, or conditions requiring treatment with an int

236 cales of Infant and Toddler Development III, blindness, or deafness.

237 isk of dialysis/transplantation/renal death, blindness, or neuropathy.

238 s between year cohorts initiating treatment (blindness [P = 4.72 x 10(-08)], sight impaired [P = 3.27

239 xceeding the threshold for the expression of blindness phenotype.

240 rd (pwi) line, which displays a deafness and blindness phenotype.

241 of <6/18 but >/=3/60 in the better eye) and blindness (presenting visual acuity of <3/60 in the bett

242 l acuity worse than 6/18 to 3/60 inclusive), blindness (presenting visual acuity worse than 3/60), an

243 ties such as elephantiasis, skin disease and blindness, presenting a major public health burden in en

244 The glaucoma-specific blindness prevalence in Nigeria (0.7 %, 95 % CI 0.6-0.9

245 dents, 63%, 55%, 40%, 44%, and 30% reported, blindness, retinopathy, cataracts, glaucoma, and double

246 f visual impairment/severe visual impairment/blindness (RR, 0.58; 95% CI, 0.20-1.68) and unilateral i

247 mal recessive mutations in CLN3, typified by blindness, seizures, progressive cognitive and motor dec

248 tored after a transient period of congenital blindness show more efficient cortical processing of aud

249 inattentional blindness and emotion-induced blindness suggests that categorization and emotion shape

250 myosin VIIa, can cause Usher 1B, a deafness/blindness syndrome in humans, and the shaker-1 phenotype

251 etinitis pigmentosa (RP) is a major cause of blindness that affects 1.5 million people worldwide.

252 Glaucoma is a leading cause of blindness that leads to characteristic changes in the op

253 glaucoma, a common cause of vision loss and blindness that occurs without grossly abnormal intraocul

254 ets relevant to global vision impairment and blindness that were published between 1980 and 2015.

255 cones in retinitis pigmentosa (RP) leads to blindness, the administration of RdCVF is a promising th

256 In blindness, this number network colonizes parts of deaffe

257 This suggests that in blindness, this region takes on high-level linguistic fu

258 d symptoms early in life, ranging from night blindness to decreased visual acuity, and were diagnosed

259 Their reasoning also reproduces Malthus's blindness to the implications of technological innovatio

260 eld loss that leads to visual impairment and blindness; ultimately limiting personal independence and

261 , VA 20/70-20/200; severe, VA 20/200-20/400; blindness, VA <20/400.

262 directly to the abnormal ERG associated with blindness via alterations in sub-retinal space K(+) home

263 s than non-blind individuals, as expected if blindness was caused by the expression of a recessive al

264 The prevalence of VI and blindness was higher in older Chinese Americans compared

265 potentially reverse, MPS1-associated corneal blindness was investigated.

266 and myopic retinopathy; the primary cause of blindness was myopic retinopathy.

267 rm children and 0.0% of controls (P < .001), blindness was observed in 2.0% of extremely preterm chil

268 Useful vision (better than 0.1, legal blindness) was achieved for 8 of 9 children in cohort 1

269 ng low vision, severe visual impairment, and blindness were 18, 32, and 44 years, respectively, with

270 Cumulative lifetime risks of low vision and blindness were estimated using Kaplan-Meier survival ana

271 Cases involving legal blindness were more likely to result in verdicts in favo

272 Prevalence of VI and blindness were reported by age, sex, race/ethnicity, and

273 or 'analogue' of human onchocerciasis (river blindness), which is caused by Onchocerca volvulus.

274 , neurological disorders, liver failure, and blindness, which could collectively be lethal.

275 aucoma also agreed the disease can result in blindness with only (28 %) affirming that blindness from

276 Glaucoma is a leading cause of blindness, with an estimated world-wide prevalence of 3.

277 ta to show that the pattern of occurrence of blindness within and across affected families that produ

278 e disease of photoreceptor cells that causes blindness within the first year of life.

279 glaucoma, the leading cause of irreversible blindness world-wide.

280 Glaucoma is the second leading cause of blindness worldwide and its pathogenesis remains unclear

281 ATEMENT Glaucoma is the most common cause of blindness worldwide and, along with other optic neuropat

282 Glaucoma is a leading cause of blindness worldwide, and is characterized by progressive

283 d with glaucoma, the second leading cause of blindness worldwide, and with its major risk factor, int

284 her constitute a leading cause of hereditary blindness worldwide, are largely untreatable.

285 Glaucoma, the leading cause of irreversible blindness worldwide, is characterized by the selective d

286 reatment for cataracts, the leading cause of blindness worldwide, is to extract the cataractous lens

287 laucoma is the leading cause of irreversible blindness worldwide.

288 Glaucoma is a major cause of irreversible blindness worldwide.

289 ually transmitted infections and preventable blindness worldwide.

290 turity (ROP) is a leading cause of childhood blindness worldwide.

291 se, which is the leading infectious cause of blindness worldwide.

292 closure glaucoma (PACG) is a major cause of blindness worldwide.

293 disease and an important cause of childhood blindness worldwide.

294 glaucoma is a leading cause of irreversible blindness worldwide.

295 -angle glaucoma (POAG) is a leading cause of blindness worldwide.

296 laucoma is the leading cause of irreversible blindness worldwide.

297 enerative diseases are the leading causes of blindness worldwide.

298 t is the most frequent cause of irreversible blindness worldwide.

299 for secondary glaucoma and a major cause of blindness worldwide.

300 ed infection and leading infectious cause of blindness, yet it is one of the least understood human p